Develops CRISPR/Cas9, TALEN and zinc-finger editing in cells and mouse models. Applies these tools to gene therapy, regenerative medicine and disease modeling.
44 papers since 2024
›
Epigenome editing technologies for discovery and medicine
Nature Biotechnology, 2024
Deciphering the impact of genomic variation on function
Nature, 2024
Multicenter integrated analysis of noncoding CRISPRi screens
Runs 10x Genomics Chromium, Visium and Xenium assays and analyzes whole-genome, exome and bulk RNA-seq data. Studies brain tumors, MS and Alzheimer’s disease with collaborators.
66 papers since 2024
›
Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction
Nature Communications, 2025
Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche
Acta Neuropathologica Communications, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
Develops statistical methods for exome sequencing, whole-genome sequencing and case-parent sequencing data. Applies them to susceptibility loci, rare variants and complex disease-gene mapping.
21 papers since 2024
›
Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSER
Cell Genomics, 2025
Bayesian estimation of allele-specific expression in the presence of phasing uncertainty
Bioinformatics, 2025
Deciphering the impact of genomic variation on function
Analyzes clinical, genomic, basic-science, microarray and proteomic data with statistical modeling and machine learning. Supports research within Duke Anesthesiology.
44 papers since 2024
›
An osteoarthritis pathophysiological continuum revealed by molecular biomarkers
Science Advances, 2024
A multi-ancestry GWAS of Fuchs corneal dystrophy highlights the contributions of laminins, collagen, and endothelial cell regulation
Communications Biology, 2024
Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors
Develops AAV, lentiviral and CRISPR-based gene-editing tools through custom cloning and vector production. Supports basic and translational rare-disease research.
9 papers since 2024
›
Cell-specific DNA methylation in human alpha and beta cells regulates gene expression in type 2 diabetes
Nature Metabolism, 2026
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease
Molecular Therapy — Nucleic Acids, 2025
The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders
Analyzes single-cell multi-omics, ATAC-seq, ECoG, EEG and MEG data in neurological disease and cognition. Develops Alzheimer’s mouse models and therapies.
1 paper since 2024
›
A diagnostic plasma omics-biomarker for Alzheimer’s disease informed by microglial single-cell transcriptomics: A pilot study
Funded by National Institute on Aging, National Institutes of Health +3 more
›
National Institute of Diabetes and Digestive and Kidney Diseases, The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC) · 2024 - 2029
“Research Co-Principal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029”
National Institute on Aging, Untangling the diversity in the genetic architecture of late-onset Alzheimer's disease using single cell multi-omics · 2026 - 2028
“"Untangling the diversity in the genetic architecture of late-onset Alzheimer's disease using single cell multi-omics"; "Awarded by National Institute on Aging"; "2026 - 2028"”
National Institutes of Health, Untangling the diversity in the genetic architecture of late-onset Alzheimer's disease using single cell multi-omics · 2022 - 2027
“Research Principal Investigator · Awarded by National Institutes of Health · 2022 - 2027”
Studies transcriptional regulation with iPSCs, single-cell RNA-seq, ATAC-seq and comparative genomics. Research spans primates, sea urchins and Heliconius butterflies to explain regulatory evolution.
23 papers since 2024
›
A human-specific enhancer fine-tunes radial glia potency and corticogenesis
Nature, 2025
Lepidopteran scale cells derive from sensory organ precursors through a canonical lineage